CRMD vs. PODD
CRMD (CorMedix Inc.) and PODD (Insulet Corporation) are both stocks. Both are in the Healthcare sector — CRMD in Biotechnology, PODD in Medical Devices. Over the past 10 years, CRMD returned -1.91%/yr vs 17.35%/yr for PODD. At a 0.16 correlation, their price movements are largely independent.
Performance
CRMD vs. PODD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRMD achieves a -24.85% return, which is significantly higher than PODD's -47.33% return. Over the past 10 years, CRMD has underperformed PODD with an annualized return of -1.91%, while PODD has yielded a comparatively higher 17.35% annualized return.
CRMD
- 1D
- -2.46%
- 1M
- 16.53%
- YTD
- -24.85%
- 6M
- -23.93%
- 1Y
- -41.18%
- 3Y*
- 15.11%
- 5Y*
- 1.21%
- 10Y*
- -1.91%
PODD
- 1D
- 0.34%
- 1M
- 0.58%
- YTD
- -47.33%
- 6M
- -49.37%
- 1Y
- -50.69%
- 3Y*
- -18.98%
- 5Y*
- -11.92%
- 10Y*
- 17.35%
CRMD vs. PODD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CRMD CorMedix Inc. | -24.85% | 43.58% | 115.43% | -10.90% | -7.25% | -38.76% | 2.06% | 12.87% | 158.00% | -67.32% |
PODD Insulet Corporation | -47.33% | 8.88% | 20.32% | -26.30% | 10.64% | 4.08% | 49.32% | 115.83% | 14.96% | 83.12% |
Correlation
The correlation between CRMD and PODD is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 13, 2010 | 0.16 |
Fundamentals
CRMD:
$812.69M
PODD:
$10.51B
CRMD:
$2.10
PODD:
$4.29
CRMD:
4.16
PODD:
34.88
CRMD:
1.88
PODD:
3.64
CRMD:
1.86
PODD:
8.07
CRMD:
$400.05M
PODD:
$2.90B
CRMD:
$343.39M
PODD:
$2.06B
CRMD:
$207.97M
PODD:
$529.70M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRMD vs. PODD — Risk / Return Rank
CRMD
PODD
CRMD vs. PODD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CorMedix Inc. (CRMD) and Insulet Corporation (PODD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CRMD | PODD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.73 | ||
| Sortino ratioReturn per unit of downside risk | +1.53 | ||
| Omega ratioGain probability vs. loss probability | 0.92 | 0.74 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | -0.66 | -0.85 | +0.19 |
| Martin ratioReturn relative to average drawdown | -0.97 | -1.78 | +0.82 |
Loading charts...
Drawdowns
CRMD vs. PODD - Drawdown Comparison
The maximum CRMD drawdown since its inception was -98.28%, which is greater than PODD's maximum drawdown of -90.28%. Use the drawdown chart below to compare losses from any high point for CRMD and PODD.
Loading charts...
Drawdown Indicators
| CRMD | PODD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.28% | -90.28% | -8.00% |
Max Drawdown (1Y)Largest decline over 1 year | -62.26% | -59.63% | -2.63% |
Max Drawdown (3Y)Largest decline over 3 years | -62.26% | -59.63% | -2.63% |
Max Drawdown (5Y)Largest decline over 5 years | -66.91% | -61.31% | -5.60% |
Max Drawdown (10Y)Largest decline over 10 years | -94.77% | -61.31% | -33.46% |
Current DrawdownCurrent decline from peak | -82.29% | -57.57% | -24.72% |
Average DrawdownAverage peak-to-trough decline | -77.55% | -24.99% | -52.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.56% | 28.42% | +14.14% |
Volatility
CRMD vs. PODD - Volatility Comparison
The current volatility for CorMedix Inc. (CRMD) is 12.12%, while Insulet Corporation (PODD) has a volatility of 13.00%. This indicates that CRMD experiences smaller price fluctuations and is considered to be less risky than PODD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CRMD | PODD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.12% | 13.00% | -0.88% |
Volatility (6M)Calculated over the trailing 6-month period | 51.58% | 30.47% | +21.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 68.31% | 38.15% | +30.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.11% | 42.74% | +34.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.70% | 42.54% | +49.16% |
Dividends
CRMD vs. PODD - Dividend Comparison
Neither CRMD nor PODD has paid dividends to shareholders.
Financials
CRMD vs. PODD - Financials Comparison
This section allows you to compare key financial metrics between CorMedix Inc. and Insulet Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CRMD vs. PODD - Profitability Comparison
CRMD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a gross profit of 105.12M and revenue of 127.43M. Therefore, the gross margin over that period was 82.5%.
PODD - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported a gross profit of 529.10M and revenue of 761.70M. Therefore, the gross margin over that period was 69.5%.
CRMD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported an operating income of 63.66M and revenue of 127.43M, resulting in an operating margin of 50.0%.
PODD - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported an operating income of 122.10M and revenue of 761.70M, resulting in an operating margin of 16.0%.
CRMD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CorMedix Inc. reported a net income of 38.60M and revenue of 127.43M, resulting in a net margin of 30.3%.
PODD - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Insulet Corporation reported a net income of 91.10M and revenue of 761.70M, resulting in a net margin of 12.0%.
Frequently Asked Questions
CRMD and PODD have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PODD has higher volatility (13.00%) compared to CRMD (12.12%). In terms of maximum drawdown, CRMD dropped -98.28% vs PODD's -90.28%.
CRMD currently has the higher Sharpe Ratio (-0.60 vs -1.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CRMD and PODD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer